Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

Human telomerase reverse transcriptase (hTERT) is a target antigen for cancer immunotherapy in patients with non-small cell lung cancer (NSCLC). We have tested a novel hTERT vaccine, UV1, designed to give high population coverage. UV1 is composed of three synthetic long peptides containing multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunsvig, Paal F., Guren, Tormod Kyrre, Nyakas, Marta, Steinfeldt-Reisse, Claudius H., Rasch, Wenche, Kyte, Jon Amund, Juul, Hedvig Vidarsdotter, Aamdal, Steinar, Gaudernack, Gustav, Inderberg, Else Marit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726017/
https://www.ncbi.nlm.nih.gov/pubmed/33324397
http://dx.doi.org/10.3389/fimmu.2020.572172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726017/
https://www.ncbi.nlm.nih.gov/pubmed/33324397
http://dx.doi.org/10.3389/fimmu.2020.572172

Ejemplares similares